- Research article
- Open Access
- Open Peer Review
Characteristics of syphilitic uveitis in northern China
© The Author(s). 2017
- Received: 12 October 2016
- Accepted: 8 June 2017
- Published: 19 June 2017
To describe the characteristics of patients with syphilitic uveitis in northern China.
A case series of 21 patients (33 eyes) diagnosed with syphilitic uveitis from 2011 to 2016 at a tertiary center in northern China was retrospectively analyzed.
Twenty-one patients (33 eyes) were diagnosed as syphilitic uveitis. Posterior segment involvement was found in 32 eyes (97.0%). Vitreous haze, neuroretinitis, and posterior placoid chorioretinitis were mainly found in patients with a relatively short duration of the disease, while diffuse chorioretinitis, pseudoretinitis pigmentosa, cystoid macular edema, and epiretinal membrane were found in patients with relatively long duration of ocular involvement. A low best-corrected visual acuity (P = 0.022) and a delay of syphilis treatment (P < 0.001) were associated with a significantly worse visual outcome.
Syphilitic uveitis should be included in the differential diagnosis of any form of posterior ocular inflammation. The pattern of ocular involvement may change with the disease progression.
- Syphilitic uveitis; chorioretinitis
- Posterior placoid chorioretinitis
- Pseudoretinitis pigmentosa
Syphilitic uveitis has recently regained attention due to the worldwide resurgence of syphilis [1–12]. Syphilis is a sexually transmitted, systemic infection caused by the spirochete Treponema pallidum. The clinical course of syphilis is typically divided into four stages, including primary, secondary, latent, and tertiary stages. Ocular involvement in syphilis can occur at any stage except in the primary stage, but occurs most often during the secondary or latent stages . Syphilitic uveitis is the most common site of ocular syphilis. The reported incidence of syphilis among patients presenting at uveitis referral centers has significantly varied between studies, ranging from 0.4% in a Chinese study  in 2012 to 8% in a study from New York in 1997 .
Syphilitic uveitis is described as a “great masquerader” for its variable clinical manifestations that mimic other types of uveitis, and is often misdiagnosed, resulting in severe ocular complications and permanent visual loss [1, 2]. The purpose of this study was to describe the demographic and clinical features of a cohort of 21 patients with syphilitic uveitis over a 5-year period in a tertiary eye care center in northern China, and to assess the association between clinical and demographic data and visual outcome.
This was a retrospective review of all cases of syphilitic uveitis documented between March 2011 and March 2016 in a tertiary uveitis service at Tianjin Medical University Eye Hospital. Approval for this study was obtained from Ethics Review Committee of Tianjin Medical University Eye Hospital (No. 2016KY(L)-08). Demographic and clinical data were collected from patient records, including age, gender, race, ocular and systemic history, presenting complaint, best-corrected visual acuity (BCVA), ophthalmic examination findings, concomitant systemic findings, laboratory test results, treatments, and outcomes on follow-up. Visual acuities were converted to the logarithm of the minimum angle of resolution (logMAR) for data analyses. The BCVA of counting fingers was recorded as 20/2000 for logMAR calculations.
Classification of posterior syphilitic uveitis
The inflammation of the choroid, retinal pigment epithelium and retina, with change of choroid perfusion, pigment epitheliopathy and retinal hyperfluorescence in fluorescein.
The inflammation is confined to both retina and papilla optica.
The inflammation is confined to retina.
The inflammation mainly affects papilla optica.
Primary retinal vasculitis
The inflammation mainly affects the retinal vessels.
Posterior placoid chorioretinitis
Fundus shows a yellowish, placoid, outer retinal lesion, involving the macular, with hyperfluorescence in the area of the lesion in fluorescein.
Influences of age, eye, gender, duration of the disease, previous systemic treatment, and initial BCVA on the prognoses were analyzed using SPSS statistical software for Windows, version 17.0 (SPSS, Chicago, IL, USA). Student’s t-test was used to analyze the differences of the means of final BCVA caused by gender, eye and previous systemic treatment, and Spearman’s rank correlation and Pearson linear correlation were used to correlate age, duration of the disease and initial BCVA with final BCVA. Finally, all variables were included in multiple linear regression models to identify independent risk factors that correlated with final BCVA. The eye was the unit of calculation and a P value ≤0.05 was considered to be statistically significant.
Twenty-seven patients were diagnosed with ocular syphilis, accounting for 1.9% of the total number of uveitis and scleritis patients that were referred to our department during the 5-year study period. Among these patients, 21 patients presented with syphilitic uveitis and six patients presented with scleritis. Only the documents of the 21 patients (33 eyes) with syphilitic uveitis were reviewed in this study. Both RPR and TPPA were positive in 20 patients. One patient had a negative RPR test, but a positive TPPA. Only one patient was HIV positive. The mean age at presentation was 44.9 years (range 20–64 years; median, 48 years) (Table 1). Eight patients (38.1%) were male and 13 patients were female (61.9%). Thirteen patients (61.9%) had a history of systemic manifestations of syphilis according to both the interview and the physical examination, most of which were mucocutaneous. Syphilis was first diagnosed in 18 patients (85.7%) during their first visit to our department, and only two male and one female patient were previously diagnosed with syphilis. Nine patients (42.9%) were diagnosed with secondary syphilis, two patients (9.5%) were diagnosed with neurosyphilis by lumbar puncture and 10 patients (47.6%) were diagnosed with a latent stage of syphilis. The duration between the initial symptom and the first presentation at our department ranged from 6 days to 24 months (mean 5.8 months; median, 6 months). The duration of 10 patients (47.6%) was longer than 6 months, while only that of two patients (9.5%) was less than 1 month. Twelve patients (57.1%) presented with bilateral uveitis.
Summary of demographic and clinical history of syphilitic patients (n = 21)
Demographic and clinical history
No. (%) of patients
Systemic and ocular syphilis
Ocular syphilis only
Evidence of neurosyphilis
Diagnosis of syphilis
Diagnosed after presentation
≥ 6 months
≤ 1 month; < 6 months
< 1 month
Usage of systemic immunosuppressants
≥ 2 months
≤ 0.5 month; < 2 months
< 0.5 month
Without systemic therapy
Summary of clinical characteristics of eyes with syphilitic uveitis (n = 33)
No. (%) of eyes
Blurring of vision
Type of uveitis
Posterior placoid chorioretinits
Retinal or vitreous hemorrhage
White-yellow punctuate nodules
Patchy white-yellow lesions
Cystoid macular edema
Ocular signs and duration of disease (n = 33)
No. (%) of eyes
< 6 months
≥ 6 months
Posterior placoid chorioretinits
Cystoid macular edema
Thirteen patients (61.9%) were misdiagnosed and eight patients (38.1%) were undiagnosed before referral to our department (Table 1). Ten patients had been diagnosed with autoimmune uveitis without classification, one patient as Behçet’s disease, one patient as optic neuritis, and one patient as anterior ischemic optic neuropathy. Eleven patients (52.4%) had been treated with systemic immunosuppressants (Table 1) that were usually oral prednisolone, and seven patients (33.3%) had been treated for 2 months or longer (Table 1). The patient misdiagnosed with Behçet’s disease (patient 20) had been administrated 10 months of combined corticosteroids and immunosuppressants, including methylprednisolone, prednisolone, cyclophosphamide, and chlorambucil. She visited our clinic after the fourth attack of ocular inflammation, with a visual acuity of NLP in her right eye. Fundus examination revealed severe chorioretinitis and vasculitis with vascular occlusions and white-yellow nodules scattered on the peripheral retina (Fig. 1e). Her RPR test was negative, while TPPA was positive. The ocular inflammation subsided rapidly after antibiotic therapy, leaving permanent vision loss of her right eye.
Most patients were treated with either daily intravenous penicillin G for 14–15 days or weekly intramuscular injections of benzathine penicillin G for 3 weeks (patient 2). One patient was allergic to benzathine penicillin G and received oral tetracycline for 2 weeks. Relapse occurred in this patient 3 months after the first therapy, with slight vitreous inflammation and CNV formation. Patients with anterior inflammation were given topical steroids. Oral prednisone was prescribed to all patients except patients 20 and 21, at a low and tapering dose, with a range of 15–40 mg. Ocular inflammation resolved rapidly after treatment with antibiotics in all patients. CME persisted in three eyes of two patients after antibiotic therapy, and partly resolved after sub-Tenon’s capsule injection of triamcinolone. The CNV that developed after a relapse responded to combined intravitreal injection of triamcinolone and anti-vascular endothelial growth factor. The mean follow-up time was 5.1 months (range, 1–24 months). The final BCVA was 20/40 or better in 21 eyes (63.6%), 20/50–20/200 in 11 eyes (33.3%), and worse than 20/200 in one eye (3.0%), and the median was 20/40. The BCVA improved in 27 eyes (81.8%), was unchanged in seven eyes (21.2%), and worsened in one eye (3.0%) because of CNV formation.
Associations of factors (dichotomous variable) with the final BCVA in univariate analyses
x ± s
0.685 ± 0.339
0.561 ± 0.320
0.564 ± 0.313
0.671 ± 0.350
Systemic immunosuppressive therapy
0.457 ± 0.293
0.722 ± 0.313
Associations of factors (continuous variables) with the final BCVA in univariate analyses
Factors significantly associated with the final BCVA in multiple linear regression models
In this study, we summarized the features of syphilitic uveitis in a local population of northern China. Coinfection of syphilis and HIV was only observed in one patient, and the sexual history was difficult to assess in our study because of traditional Chinese customs. Compared with other reports [4, 10], the frequency of co-infection of HIV in our patients with syphilitic uveitis was much lower, which may be due to the low prevalence of HIV in China, especially in northern China . There were more female patients than male patients in our cohort. This may have resulted because syphilis was more easily diagnosed in males in ophthalmological clinics than in women in a conservative city in northern China, and/or more female patients were regarded as refractory cases and were referred to our tertiary uveitis service. Systemic manifestations were found or retrieved in more than half of the patients, most of which were mucocutaneous. There is a general consensus that lumbar puncture should be performed on all the patients with syphilitic uveitis. However, most of the patients refused this examination due to both the cost and the risks of the operation. Considering the good prognosis of the disease and to avoid medical dispute, lumbar puncture was only performed on the patients with suspected neurosyphilis, and the results of two patients turned out to be positive.
In our department, all patients with unexplained uveitis were investigated for syphilis. Because the nonspecific test, RPR, is rapid and convenient, most of the patients were initially screened using RPR, and then confirmed by the specific test, TPPA. However, RPR was negative in patient 20, who was diagnosed as having Behçet’s disease before and at a latent stage of syphilis. Because the condition in her left eye continuously deteriorated after immunosuppressive therapy, TPPA was further examined and resulted in being positive. RPR is thought to be highly sensitive in the secondary stage, but not in the primary or tertiary stages . It has been reported that use of RPR as a screening test misses 11% of patients with ocular syphilis who had a negative RPR test . It is therefore inadequate to order a RPR test for a patient with suspected ocular syphilis.
All patients in our study had posterior involvement, and anterior segment inflammation with panuveitis was found in 39.4% of the eyes. Amaratunge et al. in 2010 reported in a literature review of 141 patients that posterior uveitis was the most common form of syphilitic uveitis in the Caucasian and African-American populations . The other two reports from China reported that posterior involvement was also the main feature of ocular syphilis in the Chinese population [5, 12]. However, this was not the case in a study from Singaporean consisting of nine (75.0% of all patients) Chinese patients who were diagnosed with isolated anterior uveitis in 33.3% of the eyes . These differences might be due to the different duration of the disease from onset to final diagnosis. The duration of the patients referred to our department ranged from 3 days to 24 months, with a mean of 5.8 months. Delayed treatment might lead to spreading of the ocular infection, for example, from the anterior to the posterior segment and from local to diffuse inflammation, thereby changing the uveitis pattern. Notably, patient 17 in our study had signs of posterior placoid chorioretinitis at the onset of the disease, but it was diagnosed 2 months later as diffuse chorioretinitis with severe vitreous haze.
The distribution of the type of posterior segment presentation has shown great variability in different studies. The difference may be due to both the discrepancy in duration of the disease as discussed above and the diversity of classification criteria. In our study, consistent with the report of Villanueva et al. , diffuse chorioretinitis (19 eyes, 57.6%) was the most common presentation, and was the only manifestation in patients with a duration >6 months, while in patients with a duration <6 months, neuroretinitis was the most common diagnosis. In addition, vitreous haze and posterior placoid chorioretinitis were other symptoms mainly observed in patients with short duration of the disease, while pseudoretinitis pigmentosa, CME, and epiretinal membrane were found in patients with long history of ocular involvement. These results also suggested that the infection might spread in the eye without effective therapy, and a typical severe disease might develop from local inflammation to diffuse chorioretinitis with vitreous haze, and finally result in pseudoretinitis pigmentosa. Antibiotic treatment can still improve the visual acuity at the later stages of the disease, but fails to broaden the visual field effectively once the outer layer of the retina and RPE is widely destroyed, emphasizing the importance of early diagnosis.
Posterior placoid chorioretinitis is an uncommon but distinct manifestation of ocular syphilis, which is characterized by a large, placoid, yellowish, outer retinal lesion with hyperfluorescence in FA and slightly increased autofluorescence [20, 21]. Eandi et al. reported a series of 16 cases with active posterior placoid chorioretinitis collected from 12 retina practices in the United States and Europe in 2012, and retrieved 44 previously reported patients, suggesting that all patients with signs of posterior placoid chorioretinitis should be tested for syphilis . Two patients were diagnosed with posterior placoid chorioretinitis in our case series, who experienced good vision recovery after antibiotic therapy.
Consistent with recent reports, nongranulomatous inflammation was more frequent in our study. Granulomatous uveitis was observed in only one patient, with mutton fat KPs. The inner precipitates found in patient 17 were white-yellowish masses with varying sizes that were attached to the peripheral posterior vitreous membrane, while in patient 21 with a coinfection of syphilis and HIV, multiple mutton fat-like precipitates were observed. These kinds of precipitates have been previously described in several reports, and were thought to represent granulomas comprised of bacteria and inflammatory cells [5, 23–26]. Yang et al. suggested that these structures might be a diagnostic and/or predictive parameter for ocular syphilis .
Corticosteroid therapy can temporarily improve the symptoms of patients with syphilitic uveitis, and this improvement might be mistakenly regarded as an indication of proper treatment. However, syphilitic uveitis can sometimes subsequently worsen with the development of the disease [11, 17, 27]. It has therefore been suggested that corticosteroid should never be used alone to treat syphilis . In our study, multivariate linear regression analyses revealed that only the duration of the disease and the initial BCVA independently correlated with a worse prognosis, while the usage of systemic corticosteroid treatment did not affect visual acuity outcomes independently. It has been reported in a recent report enrolling 85 patients that the mean visual acuity at the start of syphilis treatment was better in patients receiving steroid therapy, indicating a potential beneficial effect of steroid treatment . The CME responded to periocular injection of steroids in our patients, indicating that steroids may be useful for controlling the inflammation when used together with effective antibiotic therapy. In addition, steroids have been suggested to be used together with antibiotic therapy to reduce the incidence of the Jarisch–Herxheimer reaction . Taken together, we suggest a combination of steroid and antibiotic therapy for syphilitic uveitis, especially in severe cases.
In conclusion, syphilitic uveitis is commonly overlooked in China, and should be included in the differential diagnosis of any form of posterior ocular inflammation due to its variety of clinical manifestation. The pattern of ocular involvement may change with the development of the disease. Neuroretinitis and diffuse chorioretinitis with vitreous haze are the typical presentations, which may result in pseudoretinitis pigmentosa without efficient therapy. Early treatment of syphilis will lead to a good visual prognosis, while a delay in therapy may lead to severe ocular complications.
We gratefully acknowledge Dr. Changping Li, for the help of statistic analysis.
Availability of data and materials
The datasets generated and/or analysed during the current study are not all publicly available in order to protect patient anonymity, but are available from the corresponding author on reasonable request.
XZ analyzed and interpreted the patient data, and was the major contributor in writing the manuscript. QD, MW and YL collected the patient data. FM made the statistic analysis. XL conceived and designed the research, provided administrative support, and contributed in manuscript writing. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
The consent for publication of all data has been obtained from each patient.
Ethics approval and consent to participate
This was a retrospective review of cases of syphilitic uveitis. Approval for this study was obtained from the institutional review board of Tianjin Medical University Eye Hospital.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Chao JR, Khurana RN, Fawzi AA, Reddy HS, Rao NA. Syphilis: reemergence of an old adversary. Ophthalmology. 2006;113:2074.View ArticlePubMedGoogle Scholar
- Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye. 2006;20:703.View ArticlePubMedGoogle Scholar
- Hughes EH, Guzowski M, Simunovic MP, Hunyor AP, McCluskey P. Syphilitic retinitis and uveitis in HIV-positive adults. Clin Experiment Ophthalmol. 2010;38:851.View ArticlePubMedGoogle Scholar
- Li SY, Birnbaum AD, Tessler HH, Goldstein DA. Posterior syphilitic uveitis: clinical characteristics, co-infection with HIV, response to treatment. Jpn J Ophthalmol. 2011;55:486.View ArticlePubMedGoogle Scholar
- Yang P, Zhang N, Li F, Chen Y, Kijlstra A. Ocular manifestations of syphilitic uveitis in Chinese patients. Retina. 2012;32:1906.View ArticlePubMedGoogle Scholar
- Restivo L, Abbouda A, Nardella C, Bruscolini A, Pirraglia MP, Pivetti PP. Uveitis heralding previously unknown luetic and HIV infection. Syphilitic uveitis in an Italian referral center Ann Ist Super Sanita. 2013;49:133.Google Scholar
- Yap SC, Tan YL, Chio MT, Teoh SC. Syphilitic uveitis in a Singaporean population. Ocul Immunol Inflamm. 2014;22:9.View ArticlePubMedGoogle Scholar
- Cunningham EJ, Eandi CM, Pichi F. Syphilitic uveitis. Ocul Immunol Inflamm. 2014;22:2.View ArticlePubMedGoogle Scholar
- Northey LC, Skalicky SE, Gurbaxani A, McCluskey PJ. Syphilitic uveitis and optic neuritis in Sydney. Australia Br J Ophthalmol. 2015;99:1215.View ArticlePubMedGoogle Scholar
- Fonollosa A, Martinez-Indart L, Artaraz J, Martinez-Berriotxoa A, Agirrebengoa K, Garcia M, et al. Clinical manifestations and outcomes of syphilis-associated uveitis in northern Spain. Ocul Immunol Inflamm. 2016;24:147.PubMedGoogle Scholar
- Bollemeijer JG, Wieringa WG, Missotten TO, Meenken I, ten Dam-van Loon NH, Rothova A, et al. Clinical manifestations and outcome of syphilitic uveitis. Invest Ophthalmol Vis Sci. 2016;57:404.View ArticlePubMedGoogle Scholar
- Zhang R, Qian J, Guo J, Yuan Y, Xue K, Yue H, et al. Clinical manifestations and treatment outcomes of syphilitic uveitis in a Chinese population. J Ophthalmol. 2016;2016:2797028.PubMedPubMed CentralGoogle Scholar
- Barile GR, Flynn TE. Syphilis exposure in patients with uveitis. Ophthalmology. 1997;104:1605.View ArticlePubMedGoogle Scholar
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol. 2005;140:509.PubMedGoogle Scholar
- Villanueva AV, Sahouri MJ, Ormerod LD, Puklin JE, Reyes MP. Posterior uveitis in patients with positive serology for syphilis. Clin Infect Dis. 2000;30:479.View ArticlePubMedGoogle Scholar
- Tang S, Tang W, Meyers K, Chan P, Chen Z, Tucker JD. HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review. BMC Infect Dis. 2016;16:588.View ArticlePubMedPubMed CentralGoogle Scholar
- Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. 2000;107:2015.View ArticlePubMedGoogle Scholar
- Shalaby IA, Dunn JP, Semba RD, Jabs DA. Syphilitic uveitis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1997;115:469.View ArticlePubMedGoogle Scholar
- Amaratunge BC, Camuglia JE, Hall AJ. Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients. Clin Experiment Ophthalmol. 2010;38:68.View ArticlePubMedGoogle Scholar
- de Souza EC, Jalkh AE, Trempe CL, Cunha S, Schepens CL. Unusual central chorioretinitis as the first manifestation of early secondary syphilis. Am J Ophthlamol. 1988;105:271.View ArticleGoogle Scholar
- Gass JDM, Braunstein RA, Chenoweth RG. Acute syphilitic posterior placoid chorioretinitis. Ophthalmology. 1990;97:1288.View ArticlePubMedGoogle Scholar
- Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr. International Syphilis Study Group. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina. 2012;32:1915.Google Scholar
- Aldave AJ, King JA, Cunningham ET Jr. Ocular syphilis. Curr Opin Ophthalmol. 2001;12:433.View ArticlePubMedGoogle Scholar
- Wickremasinghe S, Ling C, Stawell R, Yeoh J, Hall A, Zamir E. Syphilitic punctate inner retinitis in immunocompetent gay men. Ophthalmology. 2009;116:1195.View ArticlePubMedGoogle Scholar
- Fu EX, Geraets RL, Dodds EM, Echandi LV, Colombero D, HR MD, et al. Superficial retinal precipitates in patients with syphilitic retinitis. Retina. 2010;30:1135.View ArticlePubMedGoogle Scholar
- Chhablani JK, Biswas J, Sudharshan S. Panuveitis as a manifestation of ocular syphilis leading to HIV diagnosis. Oman J Ophthalmol. 2010;3:29.View ArticlePubMedPubMed CentralGoogle Scholar
- Ross WH, Sutton HFS. Acquired syphilis uveitis [case report]. Arch Ophthalmol. 1980;98:496–8.View ArticlePubMedGoogle Scholar
- Solebo AL, Westcott M. Corticosteroids in ocular syphilis. Ophthalmology. 2007;114:1593.View ArticlePubMedGoogle Scholar